Cardiovascular Pharmacology involves the study of how drugs interact with the cardiovascular system to produce their effects. These effects are typically characterized by changes in the function of the heart, blood vessels, and other components of the circulatory system. Pharmacodynamic considerations include the mechanisms by which drugs exert their influence, such as receptor interactions, signal transduction pathways, and alterations in cellular function.
For instance, beta-blockers act by blocking beta-adrenergic receptors, leading to reduced heart rate and contractility. Calcium channel blockers inhibit the entry of calcium ions into cardiac and smooth muscle cells, resulting in vasodilation and decreased cardiac contractility. Antiplatelet agents, like aspirin, interfere with platelet function to prevent blood clot formation.
Understanding pharmacodynamics is crucial in tailoring drug therapy for cardiovascular conditions, as it allows for precise targeting of specific pathways to achieve therapeutic effects while minimizing adverse reactions. It plays a vital role in optimizing treatment strategies for conditions such as hypertension, heart failure, and arrhythmias.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia